The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

The Ministry of Public Health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...

Nurses at Saint Vincent Hospital in Worcester allege that cost-saving measures are causing pervasive lapses in care, including two patients dying after failing to receive potentially life-saving ...

This could enable medics to identify sooner any decline in lung function. The scan method has enabled the team, led by researchers at Newcastle University, UK, to see how air moves in and out of ...

Patient education matters for diseases like multiple myeloma and other cancers. Experts say when patients learn more about their disease and understand options, it can have a big impact on treatment ...